ELISA: Use at an assay dependent dilution. Optimal dilutions/concentrations should be determined by the end user.
GTX15060 reacts equally well with enrofloxacin and its main metabolite, ciprofloxacin.
Preservative: NoneConstituents: PBS. pH 7.4
Store as concentrated solution. Centrifuge briefly prior to opening vial. For short-term storage (1-2 weeks), store at 4ºC. For long-term storage, aliquot and store at -20ºC or below. Avoid multiple freeze-thaw cycles.
1 mg/ml (Please refer to the vial label for the specific concentration.)
Enrofloxacin conjugated to KLH (keyhole limpet hemocyanin) via carbodiimide.
For laboratory use only. Not for any clinical, therapeutic, or diagnostic use in humans or animals. Not for animal or human consumption.
Ciprofloxacin, a fluoroquinolone, is a concentration dependent bactericidal agent. It is structurally related to enrofloxacin, and has a similar spectrum of activity. Both of these antimicrobials have shown activity against some gram positive aerobes and a wide range of gram negative bacilli and cocci, which include Klebsiella, Pseudomonas, Salmonella, and other organisms such as Mycoplasma, Staphylococci and Chlamydia. Due to the fluoroquinolones variable activity against most Streptococci, as well as their weak activity against many anaerobic bacteria, they are generally not recommended for use in treating infections where these types of microbes are present. Like enrofloxacin, ciprofloxacin is believed to act by inhibiting bacterial DNA gyrase which prevents DNA supercoiling and DNA synthesis.